Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126621462 | 12662146 | 2 | F | 20160825 | 20160817 | 20160831 | EXP | US-APOTEX-2016AP010492 | APOTEX | KHAN S, BLANTON MP, CHAVEZ M.. NICOTINE TOXICITY IN A NURSING HOME RESIDENT WITH DEMENTIA SECONDARY TO NICOTINE REPLACEMENT TREATMENT.;. PRIM-CARE-COMPAN-J-CLIN-PSYCHIATRY. 2016;NO. 3:18 | 73.00 | YR | F | Y | 0.00000 | 20160831 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126621462 | 12662146 | 1 | I | OLANZAPINE. | OLANZAPINE | 1 | Unknown | UNK UNK, UNKNOWN | U | 0 | TABLET | ||||||||
| 126621462 | 12662146 | 2 | PS | NICOTINE TRANSDERMAL SYSTEM | NICOTINE | 1 | Unknown | 2 MG, Q.2H. | Y | 74612 | 2 | MG | TRANSDERMAL SYSTEM | Q2H | |||||
| 126621462 | 12662146 | 3 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | UNK UNK, UNKNOWN | U | 0 | ORAL SOLUTION | ||||||||
| 126621462 | 12662146 | 4 | SS | RISPERIDONE. | RISPERIDONE | 1 | U | 0 | ORAL SOLUTION | ||||||||||
| 126621462 | 12662146 | 5 | SS | RISPERIDONE. | RISPERIDONE | 1 | U | 0 | ORAL SOLUTION | ||||||||||
| 126621462 | 12662146 | 6 | SS | AMANTADINE | AMANTADINE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126621462 | 12662146 | 1 | Product used for unknown indication |
| 126621462 | 12662146 | 2 | Product used for unknown indication |
| 126621462 | 12662146 | 3 | Agitation |
| 126621462 | 12662146 | 4 | Paranoid personality disorder |
| 126621462 | 12662146 | 5 | Dementia |
| 126621462 | 12662146 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126621462 | 12662146 | HO |
| 126621462 | 12662146 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126621462 | 12662146 | Agitation | |
| 126621462 | 12662146 | Condition aggravated | |
| 126621462 | 12662146 | Confusional state | |
| 126621462 | 12662146 | Drug ineffective | |
| 126621462 | 12662146 | Drug interaction | |
| 126621462 | 12662146 | Extrapyramidal disorder | |
| 126621462 | 12662146 | Frustration tolerance decreased | |
| 126621462 | 12662146 | Hallucination | |
| 126621462 | 12662146 | Mental impairment | |
| 126621462 | 12662146 | Toxicity to various agents | |
| 126621462 | 12662146 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |